ImageneBio, Inc. (IMA) stock news · rev $800.0K
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
This IMA news page leads with what ImageneBio, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for IMA yet. We will not pad this page with generic market recap.
Latest reported IMA revenue for 2025-12-31 was $800.0K. Net income was -$45.3M. Revenue was down 77.1% from 2024-12-31 to 2025-12-31. IMA currently screens at market cap $64.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMA stock page; for the tape open the quote page.
IMA stock news FAQ
What are IMA's latest revenue and net income?
Latest cached ImageneBio, Inc. (IMA) revenue for Dec 31, 2025 was $800.0K. Net income was -$45.3M. Statements: https://lician.com/financials/ima
How did IMA revenue change from the prior cached period?
Cached ImageneBio, Inc. (IMA) revenue was down 77.1% from $3.5M (Dec 31, 2024) to $800.0K (Dec 31, 2025). Statements: https://lician.com/financials/ima
What is IMA's market cap?
ImageneBio, Inc. (IMA) market cap is $64.7M on the latest cached fundamentals snapshot.
What kind of company is IMA?
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Where is IMA stock news listed?
Cached stock news for ImageneBio, Inc. (IMA) is listed at https://lician.com/news/ima. Filings: https://lician.com/sec/ima
Not investment advice.